Juan Deng - Publications

Impact of anti-gp210 and anti-centromere antibody dual positivity on clinical prognosis in patients with primary biliary cholangitis: risk analysis and establishment of response criteria

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: April 09, 2026

A Dual Time Window-driven Strategy to Optimize Primary Biliary Cholangitis Treatment via Alkaline Phosphatase Normalization.

Journal: Journal of clinical and translational hepatology

Published: March 17, 2026

Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteria.

Journal: Journal of translational internal medicine

Published: August 27, 2025

Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial.

Journal: Chinese medical journal

Published: April 27, 2025

Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment.

Journal: Hepatology international

Published: September 08, 2024

The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: August 19, 2024

Differences in the perceptions of patients with primary biliary cholangitis and physicians from various hospital departments: An online survey.

Journal: Journal of digestive diseases

Published: August 05, 2023

Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 29, 2023

Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria.

Journal: Hepatology international

Published: June 06, 2023

Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical Trial.

Journal: The American journal of gastroenterology

Published: February 12, 2023

Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid.

Journal: Gastroenterologia y hepatologia

Published: September 11, 2022

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion.

Journal: Hepatology international

Published: July 31, 2022